Emerging research from Workit Labs

Workit’s research team completed the first study assessing telemedicine treatment for opioid use disorder (OUD) among rural Americans post-COVID. This study, the largest sample of American OUD patients in rural areas to date, showed significant results which support the use of Workit Health’s telemedicine program to treat OUD.

Reaching rural areas

Metrics that matter


3-month retention

Compare this to 50% 3-month retention rates reported in extant studies on telemedicine-delivered OUD treatment among patients living in both rural and rural/non-rural areas.



Urinary drug tests showed 99% of participants tested positive for buprenorphine at all time points, demonstrating strong adherence to the treatment program and very little diversion.


Tested Negative for Other substances

Workit Health's focus on harm reduction encouraged participation and allowed participants to remain active and engaged without fear of dismissal, despite ~20% of participants testing positive for unexpected substances in their urinary drug screens. 

Workit Labs is committed to exploring innovations in addiction medicine and telehealth technologies through dedicated research and academic rigor.

Areas of research focus

Our current areas of study include:

mother and child on phone (1)

Download our publications

Retention in Telehealth Treatment for Opioid Use Disorder Among Rural Populations: A Retrospective Cohort Study

May 15, 2023

Published in Telemedicine and e-Health

Retention in Telehealth Treatment for Opioid Use Disorder Among Rural Populations

April 14, 2023

Poster presented at the American Society of Addiction Medicine 54th Annual Conference

This site uses cookies to improve your experience. By using this site, you consent to our use of cookies.